Detalhe da pesquisa
1.
Cardiac calcium dysregulation in mice with chronic kidney disease.
J Cell Mol Med
; 24(6): 3669-3677, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32064746
2.
Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options.
Mol Med
; 26(1): 88, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32942985
3.
A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model.
Int J Mol Sci
; 19(7)2018 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29932104
4.
Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells.
Mol Carcinog
; 55(5): 622-32, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25773758
5.
Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells.
PLoS One
; 12(5): e0177545, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28481927
6.
The regulation of NLRP3 inflammasome expression during the development of cardiac contractile dysfunction in chronic kidney disease.
Oncotarget
; 8(69): 113303-113317, 2017 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371912
7.
Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.
PLoS One
; 10(3): e0118674, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25742642